Udhayvir Grewal
ugrewalmd.bsky.social
Udhayvir Grewal
@ugrewalmd.bsky.social
Heme Onc Fellow at University of Iowa. Interested in GI Oncology and Neuroendocrine Tumors.
Reposted by Udhayvir Grewal
Excellent reflection by Udhayvir Singh Grewal on the need for improved cultural competence in healthcare and the power of perseverance when motivated by deep values

jamanetwork.com/jour...
My Turban and Tenacity
In this narrative medicine essay, an oncology fellow shares the challenges he has faced in the US medical system while wearing his turban and maintaining his beard, both of which he wears proudly as part of his Sikh identity.
jamanetwork.com
March 15, 2025 at 9:13 PM
Grateful for the opportunity to represent UIowa at NANETS24!
December 31, 2024 at 12:04 AM
Reposted by Udhayvir Grewal
Hematology-Oncology fellow Udhayvir Singh Grewal, MD (@ugrewalmd.bsky.social), and his team received Best Scientific Poster in the Clinical Research category at @NANETS1's annual conference in October. Click to learn more about the poster and the team's novel findings.
internalmedicineiowa...
Shining a light on racial disparities in neuroendocrine tumor research
The North American Neuroendocrine Tumor Society (NANETS) conference, held in Chicago this October, featured groundbreaking research, best practices in collaboration, and discussion in the field of …
internalmedicineiowa.org
December 31, 2024 at 12:00 AM
Reposted by Udhayvir Grewal
🔑 concepts in #NETs surgery

Mesenteric nodal disease classification👉🏻4 levels
4⃣ - unresectable
1⃣2⃣3⃣ - need tailored mesentery resection to spare bowel
✅Resectable if can salvage >=2 proximal SMA branches

📝 tinyurl.com/2w952fjv

#NETSky #HPBSky #SurgSky #OncSky
December 11, 2024 at 4:35 PM
A little clueless on blue sky, but want to give this a shot and see if I can get a cleaner learning experience on SM. Of course @oncothor.bsky.social @pamelakunzmd.bsky.social and @halletjulie.bsky.social had to be the first people I follow to get started with #NET discourse on @bsky.app 🦓
November 30, 2024 at 2:57 PM